Curative Biotechnology

(OTC) CUBT

Current Price$1.63

Market Cap$10.80M

Since IPO (2008)-100%

5 Year-90%

1 Year-18%

1 Month+37%

Curative Biotechnology Financials at a Glance

Market Cap

$10.80M

Revenue (TTM)

$0.00

Net Income (TTM)

$2.96M

EPS (TTM)

$-0.00

P/E Ratio

-410.26

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.63

Volume

100

Open

$1.63

Price

$1.63

Volume

100

Open

$1.63

Previous Close

$1.63

Daily Range

$1.63 - $1.63

52-Week Range

$0.03 - $2.23

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.63

Volume

100

Open

$1.63

Previous Close

$1.63

Daily Range

$1.63 - $1.63

52-Week Range

$0.03 - $2.23

CUBT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Curative Biotechnology

Industry

Biotechnology

Sector

Health Care

Employees

CEO

I. Richard Garr

Website

www.curativebiotech.com

Headquarters

Palm Beach Gardens, FL 33410, US

CUBT Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

19%

Return on Assets

-61%

Earnings Yield

-0.24%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.80M

Shares Outstanding

6.75M

Volume

100

Avg. Volume

1.94K

Financials (TTM)

Gross Profit

$87.84K

Operating Income

$1.50M

EBITDA

$1.41M

Operating Cash Flow

$868.87K

Capital Expenditure

$4.00

Free Cash Flow

$868.87K

Cash & ST Invst.

$45.04K

Total Debt

$1.36M

Curative Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$21.93K

+17.0%

Gross Margin

0.00%

N/A

Market Cap

$10.80M

N/A

Market Cap/Employee

$2.70M

N/A

Employees

N/A

Net Income

$482.00K

+46.4%

EBITDA

$260.00K

+61.8%

Quarterly Fundamentals

Name

Q1 2025YOY CHG

Net Cash

$2.89M

-36.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$3.11M

+39.0%

Return on Assets

-60.61%

N/A

Return on Invested Capital

19.14%

N/A

Free Cash Flow

$185.27K

-73.6%

Operating Cash Flow

$185.27K

-101.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TXTMProText Mobility, Inc.

TXTMProText Mobility, Inc.$0.01-3.54%

BETRFBetterLife Pharma Inc.

BETRFBetterLife Pharma Inc.$0.04-8.37%

BVAXFBioVaxys Technology Corp.

BVAXFBioVaxys Technology Corp.$0.16-4.18%

FAMDFFutura Medical plc

FAMDFFutura Medical plc$0.01+0.00%

CPMVMosaic ImmunoEngineering Inc.

CPMVMosaic ImmunoEngineering Inc.$0.33-52.81%

THERTheralink Technologies, Inc.

THERTheralink Technologies, Inc.$0.00+0.00%

NSHSFNanoSphere Health Sciences Inc.

NSHSFNanoSphere Health Sciences Inc.$0.00-57.29%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.74-0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.20-0.06%

TET1 Energy Inc.

TET1 Energy Inc.$7.00+0.23%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.32-0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.54+0.01%

FFord Motor Company

FFord Motor Company$13.03-0.03%

RIGTransocean

RIGTransocean$7.58+0.08%

Questions About CUBT

What is the current price of Curative Biotechnology?

Curative Biotechnology is trading at $1.63 per share.

What is the 52-week range for Curative Biotechnology?

Over the past 52 weeks, Curative Biotechnology has traded between $0.03 and $2.24.

How much debt does Curative Biotechnology have?

As of the most recent reporting period, Curative Biotechnology reported total debt of $1.40M.

How much cash does Curative Biotechnology have on hand?

Curative Biotechnology reported $218,263 in cash and cash equivalents in its most recent financial results.

What is Curative Biotechnology’s dividend yield?

Curative Biotechnology does not currently have a dividend yield.

Curative Biotechnology

Curative Biotechnology Financials at a Glance

CUBT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Curative Biotechnology

CUBT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Curative Biotechnology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CUBT

What is the current price of Curative Biotechnology?

What is the 52-week range for Curative Biotechnology?

How much debt does Curative Biotechnology have?

How much cash does Curative Biotechnology have on hand?

What is Curative Biotechnology’s dividend yield?

Premium Investing Services